Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 11/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20346415 | 0.92 | CNR2 (0.49) | CNR2MAOBMEN1NPC1ALDH1A1 | |
| SCHEMBL1581655 | 0.86 | LTA4H (0.55) | CNR2MEN1NPC1ALDH1A1GAA | |
| SCHEMBL3206631 | 0.82 | POLB (0.44) | POLBCNR2CNR1 | |
| SCHEMBL8927447 | 0.82 | ADRB2 (0.56) | — | |
| SCHEMBL4474958 | 0.82 | LTA4H (0.52) | POLBMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL5546322 | 0.82 | CNR2 (0.67) | CNR2MEN1MAPTKMT2ACNR1 | |
| SCHEMBL8953421 | 0.82 | POLB (0.71) | POLBCNR2L3MBTL1CNR1 | |
| SCHEMBL3210374 | 0.80 | POLB (0.50) | POLBCNR2CNR1 | |
| SCHEMBL2045876 | 0.80 | POLB (0.64) | POLBNPC1ALDH1A1MAPTRAB9A | |
| SCHEMBL21736825 | 0.79 | L3MBTL1 (0.48) | MAOBALDH1A1GAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8436083-B2 | Multifunctional self-decontaminating surface coating | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2013-05-07 | — | — | US | disclosed |
| US-20120172489-A1 | MULTIFUNCTIONAL SELF-DECONTAMINATING SURFACE COATING | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2012-07-05 | — | — | US | disclosed |
| US-7452951-B2 | Multifunctional self-decontaminating surface coating | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2008-11-18 | — | — | US | disclosed |
| US-20080102281-A1 | MULTIFUNCTIONAL SELF-DECONTAMINATING SURFACE COATING | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2008-05-01 | — | — | US | disclosed |
| US-7339015-B2 | Multifunctional self-decontaminating surface coating | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2008-03-04 | — | — | US | disclosed |
| US-20070122438-A1 | Multifunctional self-decontaminating surface coating | THE GOVERNMENT OF THE UNITED STATES, AS RESPRESENTED BY THE SECRETARY OF THE NAVY | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120172489-A1 | MULTIFUNCTIONAL SELF-DECONTAMINATING SURFACE COATING | YWHAZ, EPCAM, LBR | POLB 2087/4885CNR2 3930/4885MAOB 3267/4885 |
| US-20070122438-A1 | Multifunctional self-decontaminating surface coating | YWHAZ, EPCAM, LBR | POLB 2087/4885CNR2 3930/4885MAOB 3267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.